Rising Healthcare Expenditure Fuels Growth In The Gastroparesis Market: Transformative Forces Shaping the Gastroparesis Market Landscape in 2025

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

What Will the Gastroparesis Industry Market Size Be by 2025?
In recent times, the gastroparesis market size has been witnessing a consistent growth. It is projected to advance from $6.84 billion in 2024 to $7.17 billion in 2025, registering a compound annual growth rate (CAGR) of 4.9%. Several factors like an aging population, rising instances of diabetes, enhanced comprehension of gastrointestinal disorders, development in treatment methods, and increased awareness about gastroparesis have contributed to the growth during the historic period.

What's the Long-Term Growth Forecast for the Gastroparesis Market Size Through 2029?
The market for gastroparesis is anticipated to experience robust expansion in the upcoming years. By 2029, it's projected to reach $8.82 billion, growing at a compound annual growth rate (CAGR) of 5.3%. The predicted escalation during the forecast duration can be credited to the emergence of innovative therapeutic alternatives, the spread of tailor-made medicine methodologies, the inclusion of digital health solutions, augmentation of healthcare systems, and an intensifying focus on preliminary diagnosis. Significant trends within the forecast span involve progress in gastric electrical stimulation treatment, burgeoning investigations into stem cell therapy, the uptake of minimally invasive surgical processes, amplified utilization of health monitoring wearables, and the concentration on patient-centered care frameworks.

View the full report here:
https://www.thebusinessresearchcompany.com/report/gastroparesis-global-market-report

What Are the Key Growth Drivers Fueling the Gastroparesis Market Expansion?
The anticipated increase in healthcare spending is primed to boost the growth of the gastroparesis market. Essentially, healthcare expenditure encompasses the full spectrum of resources dedicated to healthcare services, covering costs for healthcare facilities, healthcare professionals, nursing and dental care, medications, and public health campaigns. Several factors are contributing to the rise in healthcare expenditure, including an aging population, medical technology advancements, a surge in chronic illnesses, and increased patient expectations for superior healthcare services. This increased healthcare spending is advantageous for the gastroparesis market, enabling more funding for research and development, broadening the scope of treatment options and ensuring greater patient access to specialized healthcare services. For example, a report published by the Office for National Statistics, a department of the UK government, indicated that from 2022 to 2023, healthcare costs in the UK grew by 5.6%, a significant increase compared to the 0.9% growth in 2022. The UK's healthcare expenditure in 2023 was approximately $317.63 billion (£292 billion). Consequently, the escalating healthcare expenditure is powering the growth of the gastroparesis market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12189&type=smp

What Are the Key Trends Driving Gastroparesis Market Growth?
Leading firms in the gastroparesis market are creating novel devices to boost their market earnings. These treatment devices for gastroparesis are specially designed medical instruments that aim to manage or mitigate the symptoms of gastroparesis, a disease marked by slow stomach emptying. For example, Enterra Medical Inc., a medical device corporation based in the US, unveiled its enterra therapy for gastroparesis treatment in 2022. The therapy involves an implanted neurostimulator that generates mild electrical pulses, potentially alleviating chronic nausea and vomiting symptoms related to gastroparesis. This approach is intended for people between the ages of 18 and 70 who suffer from chronic, resistant (drug-refractory) nausea and vomiting due to diabetic or idiopathic gastroparesis.

How Is the Gastroparesis Market Segmented?
The gastroparesis market covered in this report is segmented -

1) By Treatment Modality: Medications, Dietary Modifications, Medical Devices, Other Therapies
2) By Gastroparesis Type: Idiopathic, Diabetic, Post- Surgical, Other Types
3) By Patient Demographics: Pediatric Gastroparesis, Adult Gastroparesis
4) By Distribution Channel: Retail Pharmacies, Hospital Pharmacies, Other Distribution Channels
5) By End User: Hospitals And Clinics, Ambulatory Surgical Centers, Home Care Settings

Subsegments:
1) By Medications: Prokinetic Agents, Antiemetic Medications, Pain Management Medications
2) By Dietary Modifications: Low-Fiber Diets, Small, Frequent Meals, Pureed Or Liquid Diets
3) By Medical Devices: Gastric Electrical Stimulation Devices, Enteral Feeding Tubes
4) By Other Therapies: Acupuncture, Behavioral Therapies, Nutritional Supplements

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=12189&type=smp

Which Companies Are Leading the Charge in Gastroparesis Market Innovation?
Major companies operating in the gastroparesis market include Pfizer Inc., GlaxoSmithKline plc., Abbott Laboratories Inc., AstraZeneca Plc., Medtronic Plc., Takeda Pharmaceutical Company Limited, Johnson And Johnson Services Inc., Teva Pharmaceutical Industries Ltd, AbbVie Inc., Boston Scientific Corporation, Bausch Health Companies Inc., Cadila Pharmaceuticals Ltd., Daewoong Pharmaceutical co. ltd, ReGenXBio Inc., ANI Pharmaceuticals Inc., Dompe Farmaceutici S.p.A, Sucampo Pharmaceuticals Inc., Ironwood Pharmaceuticals Inc., Theravance Biopharma Inc., RedHill Biopharma Ltd., Valeant Pharmaceuticals International Inc., CinRx Pharma LLC., Ritter Pharmaceuticals Inc., Evoke Pharma Inc., Metacrine Inc., Neurogastrx Inc.

Which Regions Are Leading the Global Gastroparesis Market in Revenue?
North America was the largest region in the gastroparesis market in 2024. The regions covered in the gastroparesis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12189

This Report Supports:
1. Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2. Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3. Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4. Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.